EU/3/09/637

Table of contents

About

On 15 May 2009, orphan designation (EU/3/09/637) was granted by the European Commission to Wellstat Therapeutics EU Limited, United Kingdom, for 2',3',5'-tri-O-acetyluridine for the treatment of 5-fluorouracil overdose.

Key facts

Active substance
2',3',5'-Tri-O-acetyluridine
Disease / condition
Treatment of 5-fluorouracil overdose
Date of decision
15/05/2009
Outcome
Positive
Orphan decision number
EU/3/09/637

Sponsor's contact details

Wellstat Therapeutics EU Limited
58-60 Kensington Church Street
London W8 4DB
United Kingdom
Telephone: + 44 207 368 33 10
Telefax: + 44 207 937 34 00
E-mail: inquiries@wellstattherapeutics.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Ligue Nationale Contre le Cancer
    14 Rue Corvisart
    75013 Paris
    France
    Telephone: +33 1 53 55 24 00
    Telefax: +33 1 43 36 91 10
    E-mail: ligue@ligue-cancer.net
  • Macmillan Cancer Support
    3 Bath Place
    Rivington Street
    London EC2A 3JR
    United Kingdom
    Telephone: +44 20 7696 9003
    Telefax: +44 20 7696 9002
  • European Cancer Patient Coalition
    ECPC Office 
    Am Rothenanger 1b 
    85521 Riemerling 
    Germany 
    Telephone: +49 89 628 36 807 
    Telefax: +49 89 628 36 808
    E-mail: info@ecpc-online.org

How useful was this page?

Add your rating